TGen receives $2.5 million SU2C grant for new pancreatic cancer clinical trial
Stand Up To Cancer has awarded a $2.5 million SU2C Catalyst grant to the Translational Genomics Research Institute to investigate a revolutionary new method of treating pancreatic cancer, one of the most aggressive of all cancers.
October 12, 2017
